Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jan 2023 05:00 PM
RNS
Issue of equity and Total Voting Rights
28 Dec 2022 03:00 PM
RNS
Holding(s) in Company
23 Dec 2022 12:00 PM
RNS
Holding(s) in Company
13 Dec 2022 04:50 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Dec 2022 03:00 PM
RNS
Issue of Equity and Total Voting Rights
11 Nov 2022 04:30 PM
RNS
Director/PDMR Shareholding
11 Nov 2022 04:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Nov 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
11 Oct 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
10 Oct 2022 12:00 PM
RNS
Director/PDMR Shareholding
06 Oct 2022 05:30 PM
RNS
Block listing Interim Review
03 Oct 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
29 Sep 2022 09:00 AM
RNS
Director/PDMR Shareholding
14 Sep 2022 11:00 AM
RNS
Director/PDMR Shareholding
13 Sep 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
13 Sep 2022 07:00 AM
RNS
Interim results for the period ended 30 June 2022
12 Sep 2022 04:30 PM
RNS
Oxford Nanopore to present at upcoming conferences
01 Sep 2022 06:30 PM
RNS
Issue of Equity and Total Voting Rights
24 Aug 2022 07:00 AM
RNS
Notice of Results
11 Aug 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Aug 2022 05:30 PM
RNS
Issue of Equity and Total Voting Rights
12 Jul 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
11 Jul 2022 07:00 AM
RNS
Sale and leaseback of headquarters building
01 Jul 2022 05:16 PM
RNS
Issue of Equity and Total Voting Rights
30 Jun 2022 07:15 AM
RNS
Duncan Tatton-Brown appointed as Non-Exec Chair
23 Jun 2022 04:30 PM
RNS
Result of AGM
13 Jun 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Jun 2022 04:00 PM
RNS
Issue of Equity and Total Voting Rights
31 May 2022 06:30 PM
RNS
Director/PDMR Shareholding
26 May 2022 07:00 AM
RNS
ONT releases Remora:most comprehensive methylation
20 May 2022 07:00 AM
RNS
Oxford Nanopore announces tech updates
19 May 2022 09:06 AM
RNS
ONT opens user conference, rich science programme
13 May 2022 07:00 AM
RNS
ONT chosen for comprehensive human genome program
11 May 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
03 May 2022 04:00 PM
RNS
Issue of Equity and Total Voting Rights
12 Apr 2022 06:15 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Apr 2022 01:01 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 01:01 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 01:00 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 07:00 AM
RNS
Publication of Annual Report and Notice of AGM
06 Apr 2022 01:00 PM
RNS
Block listing Interim Review
05 Apr 2022 11:00 AM
RNS
Director/PDMR Shareholding
04 Apr 2022 02:00 PM
RNS
Genomics England expands Nanopore use in cancer
01 Apr 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
01 Apr 2022 07:00 AM
RNS
Agreement
30 Mar 2022 02:00 PM
RNS
ONT shows new high-accuracy, high-output chemistry
24 Mar 2022 07:00 AM
RNS
Nanopore sequencing profiles TB: FIND evaluation
23 Mar 2022 02:02 PM
RNS
Oxford Nanopore releases Short Fragment Mode
22 Mar 2022 07:00 AM
RNS
Preliminary Results and Guidance Update
11 Mar 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding

Oxford Nanopore Technologies develops electronic sensing systems for analyzing DNA, RNA, proteins, and other molecules including DNA sequencing, diagnostics and drug development using uses nanopore science to develop single-molecule sensing systems. Their products are used in research areas such as microbiology, human genetics, cancer research, and plant research.

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore is listed in London under the ticker ONT.

Oxford Nanopore share price listed at 615p in 2021.

UK 100